Literature DB >> 5486515

Cyclophosphamide therapy of idiopathic nephrosis.

C M Grushkin, R N Fine, E Heuser, E Lieberman.   

Abstract

Thirty-three children with steroid-dependent or steroid-resistant idiopathic nephrosis were treated with a combination of cyclophosphamide and prednisone. Remission occurred in all 23 steroid-dependent patients and, at last report, 12 had gone without any medication for periods of from two months to 21 months without relapse. Remission occurred in five of ten steroid-resistant patients. The renal biopsy findings in these patients demonstrate a correlation between the "minimal change" lesion and a positive response to cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5486515      PMCID: PMC1501850     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  13 in total

1.  The influence of hormone treatment on the natural evolution of the idiopathic nephrotic syndrome in childhood.

Authors:  K J van Acker; C Hooft
Journal:  Acta Paediatr Scand       Date:  1968-11

2.  A "silent" phase of hypocomplementemic persistent nephritis detectable by reduced serum beta-1c-globulin levels.

Authors:  J D Northway; A J McAdams; J Forristal; C D West
Journal:  J Pediatr       Date:  1969-01       Impact factor: 4.406

3.  Fatal systemic measles in a child receiving cyclophosphamide for nephrotic syndrome.

Authors:  S R Meadow; R O Weller; R W Archibald
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

4.  Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

Authors:  K N Drummond; D A Hillman; J H Marchessault; W Feldman
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

5.  Thrombosis, nephrosis, and corticosteroid therapy.

Authors:  E Lieberman; E Heuser; G S Gilchrist; G N Donnell; B H Landing
Journal:  J Pediatr       Date:  1968-09       Impact factor: 4.406

6.  Cyclophosphamide and fatal varicella.

Authors:  J I Scheinman; F W Stamler
Journal:  J Pediatr       Date:  1969-01       Impact factor: 4.406

7.  Cyclophosphamide in the treatment of idiopathic lipoid nephrosis.

Authors:  J N Etteldorf; S Roy; R L Summitt; M J Sweeney; H P Wall; W M Berton
Journal:  J Pediatr       Date:  1967-05       Impact factor: 4.406

8.  Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.

Authors:  W E Grupe; W Heymann
Journal:  Am J Dis Child       Date:  1966-11

9.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

10.  Cyclophosphamide therapy in the nephrotic syndrome in childhood.

Authors:  M W Moncrieff; R H White; C S Oggs; J S Cameron
Journal:  Br Med J       Date:  1969-03-15
View more
  3 in total

1.  The morphological and clinical course of the different forms of glomerulonephritis.

Authors:  H Fishbach; A Bohle; D Meyer; H H Edel; U Frotscher; R Kluthe; D Renner; K Rinsche; F Scheler
Journal:  Klin Wochenschr       Date:  1976-02-01

2.  Treatment of active chronic hepatitis with cyclophosphamide.

Authors:  R Naccarato; R Farini; M Chiaramonte; U Fagiolo; G C Sturniolo
Journal:  Postgrad Med J       Date:  1974-01       Impact factor: 2.401

3.  Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.

Authors:  Viktória Sümegi; Ibolya Haszon; Csaba Bereczki; Ferenc Papp; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.